Britain could use its national interest powers to veto US pharmaceutical manufacturer Pfizer’s £63bn bid for UK-based AstraZeneca, business secretary Vince Cable has said.
UPDATE: UK Pharmaceutical company AstraZeneca has rejected a buyout bid from US company Pfizer.
Conservative peer Lord Heseltine has called for greater powers for the government to intervene to prevent foreign takeovers of British firms.
The takeover of Cadbury in 2010 by Kraft Foods sparked a review of how takeovers are conducted in the UK. But as the largest takeover bid in UK history of AstraZeneca by US-giant Pfizer looms on the horizon, have any lessons really been learned?
GlaxoSmithKline and Novartis, two of the world’s largest pharmaceutical manufacturers, have announced a new multi-billion deal set to reshape both businesses.
Pfizer is reportedly in negotiations to acquire UK-based drug company AstraZeneca, the Sunday Times reported.
Pharmaceutical manufacturer GlaxoSmithKline plans to invest up to £130m into African manufacturing facilities over the next five years to increase drug production in the continent.
A new collaborative model linking companies, academia and government should save the pharmaceutical industry millions and help smaller firms in Britain reorientate to supply the pharma manufacturing of tomorrow.
Fujifilm Diosynth Biotechnologies has officially opened a new biotechnology manufacturing facility in Billingham as part of a £30m investment drive.
Recruiter Clinical Professionals and the CIPD have both highlighted the threat of skills shortages and suggest strategies to overcome them.
